These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12504644)

  • 1. Prevention of Syncope Trial (POST): a randomized clinical trial of beta blockers in the prevention of vasovagal syncope; rationale and study design.
    Sheldon R; Rose S; Connolly S
    Europace; 2003 Jan; 5(1):71-5. PubMed ID: 12504644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope.
    Sheldon R; Connolly S; Rose S; Klingenheben T; Krahn A; Morillo C; Talajic M; Ku T; Fouad-Tarazi F; Ritchie D; Koshman ML;
    Circulation; 2006 Mar; 113(9):1164-70. PubMed ID: 16505178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for the Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects Trial (POST5).
    Raj SR; Faris PD; Semeniuk L; Manns B; Krahn AD; Morillo CA; Benditt DG; Sheldon RS;
    Am Heart J; 2016 Apr; 174():89-94. PubMed ID: 26995374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-dependent effect of β-blockers in preventing vasovagal syncope.
    Sheldon RS; Morillo CA; Klingenheben T; Krahn AD; Sheldon A; Rose MS
    Circ Arrhythm Electrophysiol; 2012 Oct; 5(5):920-6. PubMed ID: 22972872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized and controlled pilot trial of beta-blockers for the treatment of recurrent syncope in patients with a positive or negative response to head-up tilt test.
    Ventura R; Maas R; Zeidler D; Schoder V; Nienaber CA; Schuchert A; Meinertz T
    Pacing Clin Electrophysiol; 2002 May; 25(5):816-21. PubMed ID: 12049374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The vasovagal Syncope and pacing (Synpace) trial: rationale and study design.
    Raviele A; Giada F; Sutton R; Alboni P; Brignole M; Del Rosso A; Di Girolamo E; Luise R; Menozzi C
    Europace; 2001 Oct; 3(4):336-41. PubMed ID: 11678394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine.
    Biffi M; Boriani G; Sabbatani P; Bronzetti G; Frabetti L; Zannoli R; Branzi A; Magnani B
    Heart; 1997 Mar; 77(3):268-72. PubMed ID: 9093048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of intravenous metoprolol during positive isoproterenol tilt-table test in the choice of treatment for neurocardiogenic syncope.
    Baran I; Gemici K; Ozdemir B; Saraç M; Güllülü S; Aydinlar A; Cordan J
    Indian Heart J; 2003; 55(1):40-3. PubMed ID: 12760586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to beta blockers in patients with neurocardiogenic syncope: how to predict beneficial effects.
    Natale A; Newby KH; Dhala A; Akhtar M; Sra J
    J Cardiovasc Electrophysiol; 1996 Dec; 7(12):1154-8. PubMed ID: 8985804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial.
    Ammirati F; Colivicchi F; Santini M;
    Circulation; 2001 Jul; 104(1):52-7. PubMed ID: 11435337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study.
    Madrid AH; Ortega J; Rebollo JG; Manzano JG; Segovia JG; Sánchez A; Peña G; Moro C
    J Am Coll Cardiol; 2001 Feb; 37(2):554-9. PubMed ID: 11216978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized comparison of metoprolol versus conventional treatment in preventing recurrence of vasovagal syncope in children and adolescents.
    Zhang Q; Jin H; Wang L; Chen J; Tang C; Du J
    Med Sci Monit; 2008 Apr; 14(4):CR199-203. PubMed ID: 18376348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope.
    Connolly SJ; Sheldon R; Roberts RS; Gent M
    J Am Coll Cardiol; 1999 Jan; 33(1):16-20. PubMed ID: 9935002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemodynamic changes during head-up tilt test and predictive value thereof in predicting the efficacy of metoprolol therapy in children with vasovagal syncope].
    Zhang QY; DU JB; Zhen JL; Li WZ; Wang YL
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1260-2. PubMed ID: 17686261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale for the prevention of syncope trial IV: assessment of midodrine.
    Raj SR; Faris PD; McRae M; Sheldon RS
    Clin Auton Res; 2012 Dec; 22(6):275-80. PubMed ID: 22610268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of metoprolol on quality of life in the Prevention of Syncope Trial.
    Sheldon RS; Amuah JE; Connolly SJ; Rose S; Morillo CA; Talajic M; Kus T; Fouad-Tarazi F; Klingenheben T; Krahn AD; Koshman ML; Ritchie D;
    J Cardiovasc Electrophysiol; 2009 Oct; 20(10):1083-8. PubMed ID: 19563364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can prodromal symptoms predict recurrence of vasovagal syncope?
    Fazelifar AF; Basiri HA; Tolooie A; Haghjoo M; Barakpour H; Emkanjoo Z; Abkenar HB; Zeighami M; Asgari F; Sadr-Ameli MA
    Cardiol J; 2008; 15(5):446-50. PubMed ID: 18810720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of head-up tilt test with intravenous beta-blocker administration in assessing the efficacy of therapy in patients with vasovagal syncope.
    Gielerak G; Makowski K; Cholewa M
    Ann Noninvasive Electrocardiol; 2005 Jan; 10(1):65-72. PubMed ID: 15649240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The usefulness of tilt testing with an intravenous beta-blocker in assessing the efficacy of long-term therapy in patients with vasovagal syncope.
    Gielerak G; Makowski K; Dłuzniewska E; Stec A; Cholewa M
    Kardiol Pol; 2003 Aug; 59(8):93-104; commentary 103-4. PubMed ID: 14560324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Second Prevention of Syncope Trial (POST II)--a randomized clinical trial of fludrocortisone for the prevention of neurally mediated syncope: rationale and study design.
    Raj SR; Rose S; Ritchie D; Sheldon RS;
    Am Heart J; 2006 Jun; 151(6):1186.e11-7. PubMed ID: 16781217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.